NanoSphere Health Sciences Inc.
NSHSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $206 | $39 | $411 | $288 |
| - Cash | $2 | $4 | $2 | $2 |
| + Debt | $45 | $48 | $35 | $31 |
| Enterprise Value | $248 | $83 | $444 | $316 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$16 | -$57 | $408 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$16 | -$97 | $407 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.002 | -0.009 | 0.04 |
| % Growth | 100% | 84% | -123.7% | – |
| Operating Cash Flow | -$66 | $22 | $52 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$66 | $22 | $52 | -$15 |